首页> 外文期刊>JAIDS: Journal of acquired immune deficiency syndromes >Risk factors of isolated antibody against core antigen of hepatitis B virus: association with HIV infection and age but not hepatitis C virus infection.
【24h】

Risk factors of isolated antibody against core antigen of hepatitis B virus: association with HIV infection and age but not hepatitis C virus infection.

机译:乙型肝炎病毒核心抗原分离抗体的危险因素:与HIV感染和年龄相关,但与丙型肝炎病毒感染无关。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Isolated antibody to hepatitis B core antigen (anti-HBc) is defined as seropositivity for anti-HBc in the absence of hepatitis B surface antigen (HBsAg) and antibody to HBsAg (anti-HBs). It is commonly found in HIV-infected persons or hepatitis C virus (HCV)-infected persons, but the risk factors for isolated anti-HBc remain uncertain, especially in regions that are hyperendemic for hepatitis B virus (HBV) infection. METHODS: This cross-sectional study included a cohort of 955 nonhemophiliac, HIV-infected patients, diagnosed between 1988 and 2009, and 643 HIV-uninfected injection drug users (IDUs) attending the methadone clinic between August 2007 and May 2009, with available HBV serological data. The medical records were reviewed to identify the risk factors associated with seropositivity of isolated anti-HBc. RESULTS: The overall seroprevalence of isolated anti-HBc was 12.1% (193 of 1598), in which occult HBV infection accounted for 1.6% (3 of 185) and the majority (91.2 %, 176 of 193) had low titers of anti-HBs (3.6 +/- 2.9 IU/L). Subjects with isolated anti-HBc were significantly older (40.7 +/- 9.3 versus 36.9 +/- 8.0, respectively, P < 0.0001). There was a significantly increasing trend in the prevalence of isolated anti-HBc with age, from 4.0% in those younger than 30 years to 22.5% after 50 years of age (test for trend, P < 0.0001). A significantly higher prevalence of isolated anti-HBc was observed in HIV-infected subjects [14.0% (134 of 955) versus 9.2% (59 of 643), adjusted odds ratio, 1.64; P < 0.01], but not in those with HCV infection (P = 0.18). CONCLUSIONS: Isolated anti-HBc seropositivity was significantly associated with HIV infection, and older age. HCV infection was not associated with isolated anti-HBc in a country hyperendemic with HBV infection, even in populations with a high prevalence of HCV infection. The majority was not attributable to occult HBV infection, but rather, low level of anti-HBs, suggesting that HBV vaccination may not be required.
机译:背景:针对乙型肝炎核心抗原(抗-HBc)的分离抗体被定义为在不存在乙型肝炎表面抗原(HBsAg)和抗-HBsAg(抗-HBs)的情况下抗-HBc的血清阳性。它通常在HIV感染者或丙型肝炎病毒(HCV)感染者中发现,但是分离的抗HBc的危险因素仍然不确定,尤其是在乙肝病毒(HBV)感染高流行的地区。方法:这项横断面研究包括955例在1988年至2009年之间诊断为非血友病,HIV感染的患者,以及643例在2007年8月至2009年5月间在美沙酮诊所就诊的HIV未感染的注射吸毒者(IDU),并提供了HBV血清学数据。查阅病历,以鉴定与孤立的抗HBc血清反应阳性相关的危险因素。结果:分离的抗HBc的总体血清阳性率为12.1%(1598中的193),其中隐匿性HBV感染占1.6%(185中的3),大多数(91.2%,193中的176)具有较低的抗滴度。 HBs(3.6 +/- 2.9 IU / L)。患有分离的抗HBc的受试者年龄较大(分别为40.7 +/- 9.3和36.9 +/- 8.0,P <0.0001)。分离的抗-HBc的患病率随年龄增长呈显着增加趋势,从30岁以下的4.0%上升到50岁之后的22.5%(趋势测试,P <0.0001)。在HIV感染者中观察到分离的抗-HBc的患病率显着更高[14.0%(955的134)和9.2%(643的59)],调整后的优势比为1.64; P <0.01],但在HCV感染者中则没有(P = 0.18)。结论:孤立的抗HBc血清阳性与HIV感染和年龄较大有关。在一个HBV感染的高流行国家,即使在HCV感染流行的人群中,HCV感染也与孤立的抗HBc无关。大多数不是归因于隐匿性HBV感染,而是抗HBs水平低,提示可能不需要接种HBV疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号